Deutsche Bank
CRL icon

Deutsche Bank’s Charles River Laboratories CRL Stock Holding History

Deutsche Bank’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-785
Closed -$8K – 5899
2014
Q1 		$8K Buy
+785
New +$45.8K ﹤0.01% 5082

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Deutsche Bank's CRL Position: Q2 2026 in Review

Deutsche Bank increased its Charles River Laboratories (CRL) stake by 0.43% in Q2 2026, buying an estimated $212K and bringing the position to 276,569 shares worth $62.7M. The position accounts for 0.02% of the portfolio, ranked #606.

Deutsche Bank first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $94.1M in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Deutsche Bank held 276,569 shares of Charles River Laboratories worth $62.7M as of Q2 2026.
  • Deutsche Bank bought 1,188 Charles River Laboratories shares in Q2 2026, an estimated $212K.
  • Charles River Laboratories made up 0.02% of Deutsche Bank's portfolio in Q2 2026, its #606 holding.
  • Deutsche Bank first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Charles River Laboratories position peaked at $94.1M in Q3 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.